Research ArticleOriginal Article

Heat shock protein 90 promotes RNA helicase DDX5 accumulation and exacerbates hepatocellular carcinoma by inhibiting autophagy

Ting Zhang, Xinrui Yang, Wanping Xu, Jing Wang, Dawei Wu, Zhixian Hong, Shengxian Yuan, Zhen Zeng, Xiaodong Jia, Shanshan Lu, Rifaat Safadi, Sen Han, Zhihong Yang, Leonard M. Neckers, Suthat Liangpunsakul, Weiping Zhou and Yinying Lu
Cancer Biology & Medicine August 2021, 18 (3) 693-704; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0262

References

  1. 1.↵
    2. Llovet JM,
    3. Zucman-Rossi J,
    4. Pikarsky E,
    5. Sangro B,
    6. Schwartz M,
    7. Sherman M, et al.
    Hepatocellular carcinoma. Nat Rev Dis Primers. 2016; 2: 16018.
  2. 2.↵
    2. Zhu RX,
    3. Seto WK,
    4. Lai CL,
    5. Yuen MF.
    Epidemiology of hepatocellular carcinoma in the Asia-Pacific region. Gut Liver. 2016; 10: 332–9.
    OpenUrlCrossRefPubMed
  3. 3.↵
    2. El-Serag HB,
    3. Kanwal F.
    Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014; 60: 1767–75.
    OpenUrlCrossRefPubMed
  4. 4.↵
    2. Greten TF,
    3. Papendorf F,
    4. Bleck JS,
    5. Kirchhoff T,
    6. Wohlberedt T,
    7. Kubicka S, et al.
    Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer. 2005; 92: 1862–8.
    OpenUrlCrossRefPubMed
  5. 5.↵
    2. Wang CY,
    3. Li S.
    Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: a single center 14 years experience from China. Medicine (Baltimore). 2019; 98: e14070.
  6. 6.↵
    2. Jarmoskaite I,
    3. Russell R.
    DEAD-box proteins as RNA helicases and chaperones. Wiley interdisciplinary reviews. RNA. 2011; 2: 135–52.
    OpenUrl
  7. 7.↵
    2. Wang Z,
    3. Luo Z,
    4. Zhou L,
    5. Li X,
    6. Jiang T,
    7. Fu E.
    DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating beta-catenin signaling pathway. Cancer Sci. 2015; 106: 1303–12.
    OpenUrlCrossRef
  8. 8.↵
    2. Dai TY,
    3. Cao L,
    4. Yang ZC,
    5. Li YS,
    6. Tan L,
    7. Ran XZ, et al.
    P68 RNA helicase as a molecular target for cancer therapy. J Exp Clin Cancer Res. 2014; 33: 64.
    OpenUrlCrossRef
  9. 9.↵
    2. Wang R,
    3. Jiao Z,
    4. Li R,
    5. Yue H,
    6. Chen L.
    P68 RNA helicase promotes glioma cell proliferation in vitro and in vivo via direct regulation of NF-kappaB transcription factor p50. Neuro Oncol. 2012; 14: 1116–24.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Wortham NC,
    3. Ahamed E,
    4. Nicol SM,
    5. Thomas RS,
    6. Periyasamy M,
    7. Jiang J, et al.
    The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene. 2009; 28: 4053–64.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    2. Yang L,
    3. Lin C,
    4. Liu ZR.
    Phosphorylations of DEAD box p68 RNA helicase are associated with cancer development and cell proliferation. Mol Cancer Res. 2005; 3: 355–63.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    2. Xue Y,
    3. Jia X,
    4. Li L,
    5. Dong X,
    6. Ling J,
    7. Yuan J, et al.
    DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway. Biochem Biophys Res Commun. 2018; 503: 2885–91.
    OpenUrlCrossRef
  13. 13.↵
    2. Zhang H,
    3. Zhang Y,
    4. Zhu X,
    5. Chen C,
    6. Zhang C,
    7. Xia Y, et al.
    DEAD box protein 5 inhibits liver tumorigenesis by stimulating autophagy via interaction with p62/SQSTM1. Hepatology. 2019; 69: 1046–63.
    OpenUrlPubMed
  14. 14.↵
    2. Li H,
    3. Lai P,
    4. Jia J,
    5. Song Y,
    6. Xia Q,
    7. Huang K, et al.
    RNA helicase DDX5 inhibits reprogramming to pluripotency by miRNA-based repression of RYBP and its PRC1-dependent and -independent functions. Cell Stem Cell. 2017; 20: 571.
    OpenUrlCrossRefPubMed
  15. 15.↵
    2. Pierce BG,
    3. Wiehe K,
    4. Hwang H,
    5. Kim BH,
    6. Vreven T,
    7. Weng Z.
    ZDOCK server: interactive docking prediction of protein-protein complexes and symmetric multimers. Bioinformatics. 2014; 30: 1771–3.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    2. Tomayko MM,
    3. Reynolds CP.
    Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol. 1989; 24: 148–54.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    2. Bansal H,
    3. Bansal S,
    4. Rao M,
    5. Foley KP,
    6. Sang J,
    7. Proia DA, et al.
    Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias. Blood. 2010; 116: 4591–9.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    2. Barrott JJ,
    3. Haystead TA.
    Hsp90, an unlikely ally in the war on cancer. FEBS J. 2013; 280: 1381–96.
    OpenUrlCrossRefPubMed
  19. 19.
    2. Wu Y,
    3. Huang B,
    4. Liu Q,
    5. Liu Y.
    Heat shock protein 90-beta over-expression is associated with poor survival in stage I lung adenocarcinoma patients. Int J Clin Exp Pathol. 2015; 8: 8252–9.
    OpenUrl
  20. 20.
    2. Pick E,
    3. Kluger Y,
    4. Giltnane JM,
    5. Moeder C,
    6. Camp RL,
    7. Rimm DL, et al.
    High HSP90 expression is associated with decreased survival in breast cancer. Cancer Res. 2007; 67: 2932–7.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    2. Wang C,
    3. Zhang Y,
    4. Guo K,
    5. Wang N,
    6. Jin H,
    7. Liu Y, et al.
    Heat shock proteins in hepatocellular carcinoma: molecular mechanism and therapeutic potential. Int J Cancer. 2016; 138: 1824–34.
    OpenUrl
  22. 22.↵
    2. Mbofung RM,
    3. McKenzie JA,
    4. Malu S,
    5. Zhang M,
    6. Peng W,
    7. Liu C, et al.
    HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat Commun. 2017; 8: 451.
    OpenUrlCrossRefPubMed
  23. 23.↵
    2. Wang DW,
    3. Peng ZJ,
    4. Ren GF,
    5. Wang GX.
    The different roles of selective autophagic protein degradation in mammalian cells. Oncotarget. 2015; 6: 37098–116.
    OpenUrlCrossRefPubMed
  24. 24.↵
    2. Qing G,
    3. Yan P,
    4. Xiao G.
    Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res. 2006; 16: 895–901.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    2. Wang B,
    3. Chen Z,
    4. Yu F,
    5. Chen Q,
    6. Tian Y,
    7. Ma S, et al.
    Hsp90 regulates autophagy and plays a role in cancer therapy. Tumour Biol. 2016; 37: 1–6.
    OpenUrlCrossRef
  26. 26.↵
    2. Imai J,
    3. Maruya M,
    4. Yashiroda H,
    5. Yahara I,
    6. Tanaka K.
    The molecular chaperone hsp90 plays a role in the assembly and maintenance of the 26S proteasome. EMBO J. 2003; 22: 3557–67.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    2. Tanida I,
    3. Ueno T,
    4. Kominami E.
    LC3 and autophagy. Methods Mol Biol. 2008; 445: 77–88.
    OpenUrlCrossRefPubMed
  28. 28.↵
    2. Zhang L,
    3. Yi Y,
    4. Guo Q,
    5. Sun Y,
    6. Ma S,
    7. Xiao S, et al.
    Hsp90 interacts with AMPK and mediates acetyl-coa carboxylase phosphorylation. Cell Signal. 2012; 24: 859–65.
    OpenUrlCrossRefPubMed
  29. 29.↵
    2. Kim J,
    3. Kundu M,
    4. Viollet B,
    5. Guan KL.
    AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011; 13: 132–41.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    2. Masckauchan TN,
    3. Shawber CJ,
    4. Funahashi Y,
    5. Li CM,
    6. Kitajewski J.
    Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis. 2005; 8: 43–51.
    OpenUrlCrossRefPubMed
  31. 31.↵
    2. Yang CM,
    3. Ji S,
    4. Li Y,
    5. Fu LY,
    6. Jiang T,
    7. Meng FD.
    Beta-catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco Targets Ther. 2017; 10: 711–24.
    OpenUrl
  32. 32.↵
    2. Valenta T,
    3. Hausmann G,
    4. Basler K.
    The many faces and functions of beta-catenin. EMBO J. 2012; 31: 2714–36.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    2. Kuroda T,
    3. Rabkin SD,
    4. Martuza RL.
    Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Cancer Res. 2006; 66: 10127–35.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    2. Staal FJ,
    3. van Noort M,
    4. Strous GJ,
    5. Clevers HC.
    Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep. 2002; 3: 63–8.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    2. Zhang H,
    3. Xing Z,
    4. Mani SK,
    5. Bancel B,
    6. Durantel D,
    7. Zoulim F, et al.
    RNA helicase DEAD box protein 5 regulates polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis. Hepatology. 2016; 64: 1033–48.
    OpenUrlCrossRefPubMed
  36. 36.↵
    2. Chiosis G,
    3. Timaul MN,
    4. Lucas B,
    5. Munster PN,
    6. Zheng FF,
    7. Sepp-Lorenzino L, et al.
    A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells. Chem Biol. 2001; 8: 289–99.
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    2. Blagg BS,
    3. Kerr TD.
    Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med Res Rev. 2006; 26: 310–38.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    2. Zimmer A,
    3. Amar-Farkash S,
    4. Danon T,
    5. Alon U.
    Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor. BMC Syst Biol. 2017; 11: 33.
    OpenUrl
  39. 39.↵
    2. Zhong XP,
    3. Kan A,
    4. Ling YH,
    5. Lu LH,
    6. Mei J,
    7. Wei W, et al.
    NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma. Cell Death Dis. 2019; 10: 369.
    OpenUrlCrossRef
  40. 40.↵
    2. Xiao CZ,
    3. Wei W,
    4. Guo ZX,
    5. Zhang MY,
    6. Zhang YF,
    7. Wang JH, et al.
    MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. J Cancer Res Clin Oncol. 2017; 143: 263–73.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords